exscientia Archives -

The pharmaceutical industry is increasingly relying on artificial intelligence to power its drug discovery and development efforts, and

Pharma’s spend on AI in drug discovery ‘could top $3bn by 2025’

https://pharmaphorum.com/news/pharmas-spend-on-ai-in-drug-discovery-could-top-3bn-by-2025/

News/ News/ R&D

Another big AI deal as Sanofi taps Exscientia for 15 new drugs

Phil Taylor Artifical Intellgence, digital health, drug discovery, exscientia, immunology, Oncology, partnering, Sanofi 0 Comment

If the last couple of days is an indication, 2022 is already shaping up to be the year

Another big AI deal as Sanofi taps Exscientia for 15 new drugs

https://pharmaphorum.com/news/another-big-ai-deal-as-sanofi-taps-exscientia-for-15-new-drugs/

Digital/ News/ News

AI specialist Exscientia raises $510m in upsized IPO, placing

Phil Taylor artificial intelligence, digital, digital health, drug discovery, exscientia, financing, IPO 0 Comment

Exscientia’s artificial intelligence-based drug discovery engine is still largely unproven, but that hasn’t stopped the company raking in

AI specialist Exscientia raises $510m in upsized IPO, placing

https://pharmaphorum.com/news/ai-specialist-exscientia-raises-510m-in-upsized-ipo-placing/

Digital/ News/ News

Gates Foundation ramps up funding to Exscientia in COVID project

Phil Taylor antiviral, Bill and Melinda Gates Foundation, coronavirus, COVID-19, exscientia, financing 0 Comment

The Bill & Melinda Gates Foundation must have liked what it saw in an initial collaboration with Exscientia

Gates Foundation ramps up funding to Exscientia in COVID project

https://pharmaphorum.com/news/gates-foundation-ramps-up-funding-to-exscientia-in-covid-project/

Digital/ News/ News

BMS buys into AI-designed immune drug from Exscientia

Phil Taylor artificial intelligence, Bristol-Myers Squibb, digital, digital health, drug discovery, exscientia, partnering 0 Comment

Bristol Myers Squibb has exercised an option on an immune-modulating drug candidate developed by UK artificial intelligence specialist

BMS buys into AI-designed immune drug from Exscientia

https://pharmaphorum.com/news/exscientia/

Digital/ News/ News

Gates Foundation backs COVID R&D at AI firm Exscientia

Phil Taylor artificial intelligence, coronavirus, COVID-19, drug discovery, exscientia, in silico 0 Comment

Artificial intelligence-based drug discovery company Exscientia is stepping up its search for new COVID-19 medicines, thanks to an

Gates Foundation backs COVID R&D at AI firm Exscientia

https://pharmaphorum.com/news/gates-foundation-backs-covid-rd-at-ai-firm-exscientia/

Great Britain £50 - fifty pounds sterling notes spead out.

News/ News/ R&D

UK biotech ‘booming’ as sector rakes in £1.6bn in Q2 financing

Phil Taylor Achilles Therapeutics, BIA, Biotech, Centessa, Clarivate, exscientia, Gyroscope, Life Sciences, Oxford Nanopore, UK, Vaccitech 0 Comment

The UK’s biotechnology sector is going through a purple patch, attracting almost £1.6 billion ($2.2 billion) in financing

UK biotech ‘booming’ as sector rakes in £1.6bn in Q2 financing

https://pharmaphorum.com/news/uk-biotech-booming-as-sector-rakes-in-1-6bn-in-q2-financing/

Digital/ News/ News

Exscientia buys Allcyte to add patient sample testing to its AI platform

Phil Taylor Allcyte, artificial intelligence, digital, digital health, exscientia, Oncology 0 Comment

UK-based artificial intelligence pioneer Exscientia has made a play to stay at the forefront of the field, acquiring

Exscientia buys Allcyte to add patient sample testing to its AI platform

https://pharmaphorum.com/news/exscientia-buys-allcyte-to-add-patient-sample-testing-to-its-ai-platform/

Molecular, DNA and atom model in science research lab

Digital/ News/ News

BMS embraces AI drug discovery with $1.2bn Exscientia alliance

Phil Taylor artificial intelligence, Bristol-Myers Squibb, digital, digital health, drug discovery, exscientia 0 Comment

Exscientia has signed up another big pharma partner for its artificial intelligence (AI) based drug discovery platform, this

BMS embraces AI drug discovery with $1.2bn Exscientia alliance

https://pharmaphorum.com/news/bms-embraces-ai-drug-discovery-with-1-2bn-exscientia-alliance/

Trending

exscientia

Login